Beigene Ltd (NASDAQ:BGNE)
| 140.83 Delayed Data As of Apr 08 |  +4.36 / +3.20%Today’s Change | 113.01 Today|||52-Week Range 210.35 | -15.04% Year-to-Date |
Latest BGNE News | Press Releases
No recent news for Beigene Ltd.
Today’s Trading
| Previous close | 136.04 |
| Today’s open | 138.00 |
| Day’s range | 135.78 - 141.35 |
| Volume | 210,791 |
| Average volume (3 months) | 375,674 |
| Market cap | $10.5B |
Data as of 3:59pm ET, 04/08/2020
Growth & Valuation
| Earnings growth (last year) | -30.32% |
| Earnings growth (this year) | -5.63% |
| Earnings growth (next 5 years) | +24.00% |
| Revenue growth (last year) | +116.59% |
| P/E ratio | NM |
| Price/Sales | 23.21 |
| Price/Book | 8.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TEVATeva Pharmaceutical | +0.01 | +0.10% |
| BBIOBridgeBio Pharma Inc | +2.51 | +10.28% |
| AKRXAkorn Inc | +0.00 | +1.37% |
Data as of 7:44pm ET, 04/08/2020
Financials
| Next reporting date | May 6, 2020 |
| EPS forecast (this quarter) | -$4.85 |
| Annual revenue (last year) | $428.9M |
| Annual profit (last year) | -$950.3M |
| Net profit margin | -221.53% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Beijing, Beijing |
Forecasts
